Concentra Group Holdings Parent, Inc. (CON) - Stock Analysis
Last updated: Sep 19, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Q2 revenue rose 10%, net income 46.5%, and adjusted EBITDA 22.5%; EPS beat consensus, full-year guidance was raised, and the stock gained 11.8% over 21 sessions with a rising moving average.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Margin Expansion ⢠Strong Cash Flow ⢠High Leverage CON's improving margins, cash flow, and liquidity support momentum, but high debt, intangible-asset exposure, and elevated valuation warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Above average ⢠Resistance rejection ⢠Support holding Support Level: $34.00â$34.30 (stronger at $33.74) Resistance Level: $35.80â$36.37 CON remains cautiously bullish over the last month above its 21-day average, but traders should watch $35.80â$36.37 resistance and $34.00â$34.30 support after the recent pullback.
Sentiment & News
Key News Insights: ⢠Earnings momentum ⢠Geographic expansion ⢠Leadership succession Concentra's strong earnings, 78% YTD gain, expansion plans, and leadership transition reinforce a positive growth outlook.
AI Summary
CON has evolved into a cash-generative occupational-health compounder, but after its sharp rally investors should hold or add only if margin expansion, disciplined acquisitions, and deleveraging continue, as its $2.14B debt load leaves the equity highly exposed to any growth or reimbursement miss.
Description
Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational and consumer health services, operating clinic networks and onsite programs that deliver workersâ compensation care, urgent care, preventive and clinical testing, and employer health services. The company also offers telemedicine for work-related conditions, pharmacy services, and third-party administration for medical compliance and drug testing. Founded in 1979 and headquartered in Mechanicsburg, Pennsylvania, Concentra is a subsidiary of Select Medical Corporation.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Aug 26 | Sep 2 | CON | Concentra Group Holdings Parent, Inc. | Q2 revenue rose 10%, net income 46.5%, and adjusted EBITDA 22.5%; EPS beat consensus, full-year guidance was raised, and the stock gained 11.8% over 21 sessions with a rising moving average. | Closed | -2.6% |